Table 2.
Comparison of antimicrobial susceptibilities of Acinetobacter baumannii and non-baumannii Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates.
| No. of susceptible isolates/total no. isolates tested (%) | |||
|---|---|---|---|
| Antibiotic | A. baumannii | Non-baumannii ACB complex | p-value |
| Ampicillin-sulbactam | 47/105 (45) | 24/26 (92) | < 0.01 |
| Piperacillin-tazobactam | 15/111 (14) | 21/29 (72) | < 0.01 |
| Imipenem | 29/116 (25) | 29/31 (94) | < 0.01 |
| Cefepime | 23/116 (20) | 22/31 (71) | < 0.01 |
| Ciprofloxacin | 21/116 (18) | 28/31 (90) | < 0.01 |
| Amikacin | 45/116 (39) | 27/31 (87) | < 0.01 |
| Tobramycin | 55/116 (47) | 28/31 (90) | < 0.01 |
| Minocycline | 65/110 (59) | 26/29 (90) | < 0.01 |
| Doxycycline | 50/102 (49) | 24/27 (89) | < 0.01 |
| Tigecycline | 16/67 (24) | 17/18 (94) | < 0.01 |
| Colistin | 69/72 (96) | 18/18 (100) | 1.00 |
| Multidrug resistanta | 92/116 (79) | 5/31 (16) | < 0.01 |
a
Number of multidrug resistant isolates out of total (%).